These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 34719151)

  • 1. A Rare Lymphoproliferative Disease: Castleman Disease.
    Gündüz E; Özdemir N; Bakanay ŞM; Karakuş S
    Turk J Haematol; 2021 Dec; 38(4):314-320. PubMed ID: 34719151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Castleman Disease.
    Wang W; Medeiros LJ
    Surg Pathol Clin; 2019 Sep; 12(3):849-863. PubMed ID: 31352991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multicentric Plasma-Cell Type Castleman Disease Masquerading As Hodgkin Lymphoma: A Case Report.
    Ekwere TA; Eziagu UB
    J Lab Physicians; 2020 Dec; 12(3):225-229. PubMed ID: 33268942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. From Castleman disease histopathological features to idiopathic multicentric Castleman disease: a multiparametric approach to exclude potential iMCD histopathological mimickers.
    Rodriguez Merino L; Pomares AA; Arce JR; Montes-Moreno S
    J Clin Pathol; 2024 Apr; 77(5):318-323. PubMed ID: 36690434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The management of unicentric and multicentric Castleman's disease: a report of 16 cases and a review of the literature.
    Bowne WB; Lewis JJ; Filippa DA; Niesvizky R; Brooks AD; Burt ME; Brennan MF
    Cancer; 1999 Feb; 85(3):706-17. PubMed ID: 10091744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multicentric Castleman disease of hyaline vascular variant presenting with unusual systemic manifestations: a case report.
    Basnayake BMDB; Wazil AWM; Kannangara T; Ratnatunga NVI; Hewamana S; Ameer AM
    J Med Case Rep; 2017 May; 11(1):135. PubMed ID: 28501028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis of Castleman Disease.
    Szalat R; Munshi NC
    Hematol Oncol Clin North Am; 2018 Feb; 32(1):53-64. PubMed ID: 29157619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathology of Castleman Disease.
    Wu D; Lim MS; Jaffe ES
    Hematol Oncol Clin North Am; 2018 Feb; 32(1):37-52. PubMed ID: 29157618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unicentric Castleman Disease.
    Wong RSM
    Hematol Oncol Clin North Am; 2018 Feb; 32(1):65-73. PubMed ID: 29157620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The heterogeneity of Castleman disease: report of five cases and review of the literature.
    Maslovsky I; Uriev L; Lugassy G
    Am J Med Sci; 2000 Oct; 320(4):292-5. PubMed ID: 11061358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unicentric Castleman Disease: A Rare Diagnosis of Radiological and Histological Correlation.
    Maqbool S; Javed A; Idrees T; Anwar S
    Indian J Otolaryngol Head Neck Surg; 2023 Jun; 75(2):975-978. PubMed ID: 36373120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyaline Vascular Variant of Castleman Disease of the Tonsil in an Adolescent: A case Report.
    Kishore A; Rana N; Kumar A; Kashyap V; Jebaying Y
    Indian J Otolaryngol Head Neck Surg; 2024 Feb; 76(1):1062-1065. PubMed ID: 38440559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multicentric Castleman disease: Where are we now?
    Wang HW; Pittaluga S; Jaffe ES
    Semin Diagn Pathol; 2016 Sep; 33(5):294-306. PubMed ID: 27296355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FDG-PET/ CT for initial staging and response assessment in Castleman disease - retrospective single-center study of 29 cases.
    Koukalová R; Selingerová I; Řehák Z; Adam Z; Szturz P
    Klin Onkol; 2021; 34(2):120-127. PubMed ID: 33906360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiofollicular lymph node hyperplasia (Castleman's disease).
    McCarty MJ; Vukelja SJ; Banks PM; Weiss RB
    Cancer Treat Rev; 1995 Jul; 21(4):291-310. PubMed ID: 7585657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Historical and pathological overview of Castleman disease.
    Nishimura MF; Nishimura Y; Nishikori A; Yoshino T; Sato Y
    J Clin Exp Hematop; 2022 Jun; 62(2):60-72. PubMed ID: 35474035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical implications of idiopathic multicentric castleman disease among Japanese: a report of 28 cases.
    Kojima M; Nakamura N; Tsukamoto N; Otuski Y; Shimizu K; Itoh H; Kobayashi S; Kobayashi H; Murase T; Masawa N; Kashimura M; Nakamura S
    Int J Surg Pathol; 2008 Oct; 16(4):391-8. PubMed ID: 18499694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Castleman disease: the great mimic.
    Bonekamp D; Horton KM; Hruban RH; Fishman EK
    Radiographics; 2011 Oct; 31(6):1793-807. PubMed ID: 21997995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cutaneous involvement as initial presentation of multicentric plasmacytic Castleman disease.
    Chen H; Ba W; Chen H; Yang H
    J Cutan Pathol; 2021 May; 48(5):701-705. PubMed ID: 33469928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A rare case report of hyaline-vascular type Castleman disease in the presacral region.
    Chang L; Wang S; Li J; Zhao Z; Wang M
    Front Oncol; 2024; 14():1434542. PubMed ID: 39252951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.